Clinical Trial Update: Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating anti-thrombotic strategies after transcatheter aortic valve implantation in symptomatic aortic stenosis patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis
• Transcatheter Aortic Valve Implantation

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Symptomatic Aortic Stenosis, Eligible for Transcatheter Aortic Valve Replacement | Phase 3 | Status: COMPLETED